These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37867992)

  • 1. Metabolic Abnormalities, Inflammatory Markers and Endothelial Dysfunction in Hyperprolactinemia due to Prolactinoma before and after Normalization of Serum Prolactin: A Prospective Case Control Study.
    Baba MS; Laway BA; Misgar RA; Wani AI; Bashir MI; Bhat IA; Haq MG; Shah ZA
    Indian J Endocrinol Metab; 2023; 27(4):357-364. PubMed ID: 37867992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses.
    Baba MS; Islam Mir SU; Bhat MH; Laway BA; Misgar RA
    Cureus; 2023 Aug; 15(8):e42911. PubMed ID: 37664314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline.
    Pala NA; Laway BA; Misgar RA; Dar RA
    Diabetol Metab Syndr; 2015; 7():99. PubMed ID: 26583049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study.
    Jiang XB; Li CL; He DS; Mao ZG; Liu DH; Fan X; Hu B; Zhu YH; Wang HJ
    Pituitary; 2014 Jun; 17(3):232-9. PubMed ID: 23756783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cabergoline on metabolism in prolactinomas.
    Auriemma RS; Granieri L; Galdiero M; Simeoli C; Perone Y; Vitale P; Pivonello C; Negri M; Mannarino T; Giordano C; Gasperi M; Colao A; Pivonello R
    Neuroendocrinology; 2013; 98(4):299-310. PubMed ID: 24355865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.
    Berinder K; Nyström T; Höybye C; Hall K; Hulting AL
    Pituitary; 2011 Sep; 14(3):199-207. PubMed ID: 21128120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharmacol; 2023 Aug; 63(8):886-894. PubMed ID: 37042432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular cell adhesion molecule-1 in rheumatoid arthritis patients: Relation to disease activity, oxidative stress, and systemic inflammation.
    Salem HR; Zahran ES
    Saudi Med J; 2021 Jun; 42(6):620-628. PubMed ID: 34078723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas.
    Schwetz V; Librizzi R; Trummer C; Theiler G; Stiegler C; Pieber TR; Obermayer-Pietsch B; Pilz S
    Metab Brain Dis; 2017 Feb; 32(1):155-161. PubMed ID: 27525431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between prolactin and cardiovascular disease.
    Glezer A; Santana MR; Bronstein MD; Donato J; Jallad RS
    Front Endocrinol (Lausanne); 2022; 13():1018090. PubMed ID: 36704037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients.
    Aboelnaga MM; Eladawy EH; Elshafei MM; Abdullah N; Shaer ME
    Endocr Metab Immune Disord Drug Targets; 2019; 19(4):511-518. PubMed ID: 30806330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Pilot Study.
    Portari LHC; Correa-Silva SR; Abucham J
    Neuroendocrinology; 2022; 112(1):68-73. PubMed ID: 33477154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management.
    Pekić S; Medic Stojanoska M; Popovic V
    Neuroendocrinology; 2019; 109(1):28-33. PubMed ID: 30347396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic values of adhesion molecules VCAM-1, ICAM-1 and C-reactive protein in Egyptian patients with chronic kidney disease.
    Attalah MF; Adel LA; Fahmy DE
    Egypt J Immunol; 2011; 18(2):59-66. PubMed ID: 23082471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of dopamine-agonists treatment among patients with prolactinomas.
    Kabootari M; Shirmohammadli H; Golgiri F; Mosalamiaghili S; Khajavi A; Akbari H
    Endocrine; 2023 Mar; 79(3):537-544. PubMed ID: 36352337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia.
    Ghani RA; Bin Yaakob I; Wahab NA; Zainudin S; Mustafa N; Sukor N; Wan Mohamud WN; Kadir KA; Kamaruddin NA
    J Clin Lipidol; 2013; 7(5):446-53. PubMed ID: 24079286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.
    Ciresi A; Amato MC; Guarnotta V; Lo Castro F; Giordano C
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):845-52. PubMed ID: 23506485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRL-R Variants Are Not Only Associated With Prolactinomas But Also With Dopamine Agonist Resistance.
    de Castro Moreira AR; Trarbach E; Bueno CBF; Monteiro ALS; Grande IPP; Padula M; Maciel GAR; Glezer A
    J Clin Endocrinol Metab; 2023 Jun; 108(7):e450-e457. PubMed ID: 36638053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment.
    Pirchio R; Auriemma RS; Solari D; Arnesi M; Pivonello C; Negri M; de Angelis C; Cavallo LM; Cappabianca P; Colao A; Pivonello R
    Front Endocrinol (Lausanne); 2021; 12():769744. PubMed ID: 34917030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artichoke juice improves endothelial function in hyperlipemia.
    Lupattelli G; Marchesi S; Lombardini R; Roscini AR; Trinca F; Gemelli F; Vaudo G; Mannarino E
    Life Sci; 2004 Dec; 76(7):775-82. PubMed ID: 15581909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.